Company Overview

Update
Funding:
$6.20M
Categories:
Biotechnology

Lanthio Pharma is focused on the research and development of therapeutic lantipeptide drugs for serious diseases.

Description

Update

Lanthio Pharma is a privately held drug discovery company that applies its proprietary lanthionine-peptide drug discovery technology LanthioPepTM for the generation of novel peptide therapeutics with increased resistance to peptidase degradation, high receptor specificity and increased intrinsic activity. Lanthio Pharma has generated stable, peptidase-resistant lanthionine peptides with highly specific agonistic activity for a number of GPCR targets, which is a focus area of the company.

Funding Rounds (1) - $6.20M

Update

Investors (2)

Update
  • 6311488f62da0de5cae9990db77ffc3e

    BioGeneration Ventures

    BioGeneration Ventures is investing in the next generation of Life Sciences companies in the..
  • Ba387c343cf08b9b054b963927eac62d

    INKEF Capital

    INKEF Capital’s mission is to invest in the Netherlands in companies with the potential to develop..

Offices/Locations (2)

Update
  • Office

    Groningen,

    NLD

  • Office

    Nijenborgh 4

    9747 AG Groningen

    ,

    The Netherlands

Images (1)

Update
  • 00dfdc15e55ca23663bb91352d488a87